Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Chronic Electrical Stimulation for Tear Secretion: Lacrimal vs. anterior ethmoid nerve.

Kossler AL, Brinton M, Patel ZM, Dalal R, Ta CN, Palanker D.

Ocul Surf. 2019 Aug 30. pii: S1542-0124(19)30089-8. doi: 10.1016/j.jtos.2019.08.012. [Epub ahead of print]

PMID:
31476515
2.

Withaferin A Prevents Myocardial Ischemia/Reperfusion Injury by Upregulating AMP-Activated Protein Kinase-Dependent B-Cell Lymphoma2 Signaling.

Guo R, Gan L, Lau WB, Yan Z, Xie D, Gao E, Christopher TA, Lopez BL, Ma X, Wang Y.

Circ J. 2019 Jul 25;83(8):1726-1736. doi: 10.1253/circj.CJ-18-1391. Epub 2019 Jun 20.

3.

Withaferin A inhibits apoptosis via activated Akt-mediated inhibition of oxidative stress.

Yan Z, Guo R, Gan L, Lau WB, Cao X, Zhao J, Ma X, Christopher TA, Lopez BL, Wang Y.

Life Sci. 2018 Oct 15;211:91-101. doi: 10.1016/j.lfs.2018.09.020. Epub 2018 Sep 10.

PMID:
30213729
4.

Enhanced Tearing by Electrical Stimulation of the Anterior Ethmoid Nerve.

Brinton M, Kossler AL, Patel ZM, Loudin J, Franke M, Ta CN, Palanker D.

Invest Ophthalmol Vis Sci. 2017 Apr 1;58(4):2341-2348. doi: 10.1167/iovs.16-21362.

5.

Adiponectin at Physiologically Relevant Concentrations Enhances the Vasorelaxative Effect of Acetylcholine via Cav-1/AdipoR-1 Signaling.

Du Y, Li R, Lau WB, Zhao J, Lopez B, Christopher TA, Ma XL, Wang Y.

PLoS One. 2016 Mar 29;11(3):e0152247. doi: 10.1371/journal.pone.0152247. eCollection 2016.

6.

High glucose/High Lipids impair vascular adiponectin function via inhibition of caveolin-1/AdipoR1 signalsome formation.

Liu GZ, Liang B, Lau WB, Wang Y, Zhao J, Li R, Wang X, Yuan Y, Lopez BL, Christopher TA, Xiao C, Ma XL, Wang Y.

Free Radic Biol Med. 2015 Dec;89:473-85. doi: 10.1016/j.freeradbiomed.2015.09.005. Epub 2015 Oct 8.

7.

Biocompatibility of poly(ethylene glycol) and poly(acrylic acid) interpenetrating network hydrogel by intrastromal implantation in rabbit cornea.

Zheng LL, Vanchinathan V, Dalal R, Noolandi J, Waters DJ, Hartmann L, Cochran JR, Frank CW, Yu CQ, Ta CN.

J Biomed Mater Res A. 2015 Oct;103(10):3157-65. doi: 10.1002/jbm.a.35453. Epub 2015 Mar 27.

8.

Interpenetrating polymer network hydrogel scaffolds for artificial cornea periphery.

Parke-Houben R, Fox CH, Zheng LL, Waters DJ, Cochran JR, Ta CN, Frank CW.

J Mater Sci Mater Med. 2015 Feb;26(2):107. doi: 10.1007/s10856-015-5442-2. Epub 2015 Feb 11.

PMID:
25665845
9.

Incidence of postoperative endophthalmitis from 1990 to 2009 using povidone-iodine but no intracameral antibiotics at a single academic institution.

Nentwich MM, Ta CN, Kreutzer TC, Li B, Schwarzbach F, Yactayo-Miranda YM, Kampik A, Miño de Kaspar H.

J Cataract Refract Surg. 2015 Jan;41(1):58-66. doi: 10.1016/j.jcrs.2014.04.040.

PMID:
25532634
10.

Intravitreal injection technique and monitoring: updated guidelines of an expert panel.

Avery RL, Bakri SJ, Blumenkranz MS, Brucker AJ, Cunningham ET Jr, DʼAmico DJ, Dugel PU, Flynn HW Jr, Freund KB, Haller JA, Jumper JM, Liebmann JM, McCannel CA, Mieler WF, Ta CN, Williams GA.

Retina. 2014 Dec;34 Suppl 12:S1-S18. doi: 10.1097/IAE.0000000000000399.

PMID:
25489719
11.

Successful DMEK after intraoperative graft inversion.

Yu CQ, Ta CN, Terry MA, Lin CC.

Cornea. 2015 Jan;34(1):97-8. doi: 10.1097/ICO.0000000000000311.

PMID:
25411936
12.

Climate change and land management in the rangelands of central Oregon.

Creutzburg MK, Halofsky JE, Halofsky JS, Christopher TA.

Environ Manage. 2015 Jan;55(1):43-55. doi: 10.1007/s00267-014-0362-3. Epub 2014 Sep 13.

PMID:
25216989
13.

Prevention and treatment of injection-related endophthalmitis.

Yu CQ, Ta CN.

Graefes Arch Clin Exp Ophthalmol. 2014 Jul;252(7):1027-31. doi: 10.1007/s00417-014-2644-0. Epub 2014 May 8. Review.

PMID:
24807232
14.

Emergency medicine milestones.

Beeson MS, Carter WA, Christopher TA, Heidt JW, Jones JH, Meyer LE, Promes SB, Rodgers KG, Shayne PH, Wagner MJ, Swing SR.

J Grad Med Educ. 2013 Mar;5(1 Suppl 1):5-13. doi: 10.4300/JGME-05-01s1-02. No abstract available.

15.

The emergency medicine milestones: a validation study.

Korte RC, Beeson MS, Russ CM, Carter WA; Emergency Medicine Milestones Working Group, Reisdorff EJ.

Acad Emerg Med. 2013 Jul;20(7):730-5. doi: 10.1111/acem.12166.

16.

The development of the emergency medicine milestones.

Beeson MS, Carter WA, Christopher TA, Heidt JW, Jones JH, Meyer LE, Promes SB, Rodgers KG, Shayne PH, Swing SR, Wagner MJ.

Acad Emerg Med. 2013 Jul;20(7):724-9. doi: 10.1111/acem.12157. Epub 2013 Jun 19. Review.

17.

The future of emergency medicine: update 2011.

Gardner A, Schneider SM; Future of Emergency Medicine Summit II Participants.

Ann Emerg Med. 2013 Jun;61(6):624-30. doi: 10.1016/j.annemergmed.2012.11.004. Epub 2013 Feb 5. No abstract available.

PMID:
23394842
18.

Lymphotoxin-α is a novel adiponectin expression suppressor following myocardial ischemia/reperfusion.

Lau WB, Zhang Y, Zhao J, Liu B, Wang X, Yuan Y, Christopher TA, Lopez B, Gao E, Koch WJ, Ma XL, Wang Y.

Am J Physiol Endocrinol Metab. 2013 Mar 15;304(6):E661-7. doi: 10.1152/ajpendo.00012.2013. Epub 2013 Jan 29.

19.

In vivo biocompatibility of two PEG/PAA interpenetrating polymer networks as corneal inlays following deep stromal pocket implantation.

Tan XW, Hartman L, Tan KP, Poh R, Myung D, Zheng LL, Waters D, Noolandi J, Beuerman RW, Frank CW, Ta CN, Tan DT, Mehta JS.

J Mater Sci Mater Med. 2013 Apr;24(4):967-77. doi: 10.1007/s10856-012-4848-3. Epub 2013 Jan 26.

20.

Diffusion of protein through the human cornea.

Charalel RA, Engberg K, Noolandi J, Cochran JR, Frank C, Ta CN.

Ophthalmic Res. 2012;48(1):50-5. doi: 10.1159/000329794. Epub 2012 Mar 2.

21.

Application of 10% povidone iodine reduces conjunctival bacterial contamination rate in patients undergoing cataract surgery.

Nentwich MM, Rajab M, Ta CN, He L, Grueterich M, Haritoglou C, Gandorfer A, Kampik A, Mino De Kaspar H.

Eur J Ophthalmol. 2012 Jul-Aug;22(4):541-6. doi: 10.5301/ejo.5000093.

PMID:
22180155
22.

Prevention of postcataract endophthalmitis: evidence-based medicine.

Yu CQ, Ta CN.

Curr Opin Ophthalmol. 2012 Jan;23(1):19-25. doi: 10.1097/ICU.0b013e32834cd5a9. Review.

PMID:
22081026
23.

C1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway.

Zheng Q, Yuan Y, Yi W, Lau WB, Wang Y, Wang X, Sun Y, Lopez BL, Christopher TA, Peterson JM, Wong GW, Yu S, Yi D, Ma XL.

Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2616-23. doi: 10.1161/ATVBAHA.111.231050.

24.

Toward the development of an artificial cornea: improved stability of interpenetrating polymer networks.

Hartmann L, Watanabe K, Zheng LL, Kim CY, Beck SE, Huie P, Noolandi J, Cochran JR, Ta CN, Frank CW.

J Biomed Mater Res B Appl Biomater. 2011 Jul;98(1):8-17. doi: 10.1002/jbm.b.31806. Epub 2011 Apr 18.

PMID:
21504051
25.

Morphology of Photopolymerized End-linked Poly(ethylene glycol) Hydrogels by Small Angle X-ray Scattering.

Waters DJ, Engberg K, Parke-Houben R, Hartmann L, Ta CN, Toney MF, Frank CW.

Macromolecules. 2010 Aug 24;43(16):6861-6870.

26.

Long-term clinical course of dry eye in patients with chronic graft-versus-host disease referred for eye examination.

Sáles CS, Johnston LJ, Ta CN.

Cornea. 2011 Feb;30(2):143-9. doi: 10.1097/ICO.0b013e3181e9b3bf.

PMID:
20885310
27.

The future of emergency medicine.

Schneider SM, Gardner AF, Weiss LD, Wood JP, Ybarra M, Beck DM, Stauffer AR, Wilkerson D, Brabson T, Jennings A, Mitchell M, McGrath RB, Christopher TA, King B, Muelleman RL, Wagner MJ, Char DM, McGee DL, Pilgrim RL, Moskovitz JB, Zinkel AR, Byers M, Briggs WT, Hobgood CD, Kupas DF, Kruger J, Stratford CJ, Jouriles N.

Acad Emerg Med. 2010 Sep;17(9):998-1003. doi: 10.1111/j.1553-2712.2010.00854.x. No abstract available.

28.

The future of emergency medicine.

Schneider SM, Gardner AF, Weiss LD, Wood JP, Ybarra M, Beck DM, Stauffer AR, Wilkerson D, Brabson T, Jennings A, Mitchell M, McGrath RB, Christopher TA, King B, Muelleman RL, Wagner MJ, Char DM, McGee DL, Pilgrim RL, Moskovitz JB, Zinkel AR, Byers M, Briggs WT, Hobgood CD, Kupas DF, Krueger J, Stratford CJ, Jouriles NJ.

J Emerg Med. 2010 Aug;39(2):210-5. doi: 10.1016/j.jemermed.2010.06.001. Epub 2010 Jul 15.

PMID:
20634023
29.

The future of emergency medicine.

Schneider SM, Gardner AF, Weiss LD, Wood JP, Ybarra M, Beck DM, Stauffer AR, Wilkerson D, Brabson T, Jennings A, Mitchell M, McGrath RB, Christopher TA, King B, Muelleman RL, Wagner MJ, Char DM, McGee DL, Pilgrim RL, Moskovitz JB, Zinkel AR, Byers M, Briggs WT, Hobgood CD, Kupas DF, Kruger J, Stratford CJ, Jouriles N; Future of Emergency Medicine Summit.

J Emerg Nurs. 2010 Jul;36(4):330-5. doi: 10.1016/j.jen.2010.06.013.

PMID:
20624567
30.

The future of emergency medicine.

Schneider SM, Gardner AF, Weiss LD, Wood JP, Ybarra M, Beck DM, Stauffer AR, Wilkerson D, Brabson T, Jennings A, Mitchell M, McGrath RB, Christopher TA, King B, Muelleman RL, Wagner MJ, Char DM, McGee DL, Pilgrim RL, Moskovitz JB, Zinkel AR, Byers M, Briggs WT, Hobgood CD, Kupas DF, Kruger J, Stratford CJ, Jouriles N.

Ann Emerg Med. 2010 Aug;56(2):178-83. doi: 10.1016/j.annemergmed.2010.04.011. Epub 2010 Jun 26. No abstract available.

PMID:
20580128
31.

Antibiotic susceptibility patterns of ocular bacterial flora in patients undergoing intravitreal injections.

Moss JM, Sanislo SR, Ta CN.

Ophthalmology. 2010 Nov;117(11):2141-5. doi: 10.1016/j.ophtha.2010.02.030. Epub 2010 Jun 18.

PMID:
20561687
32.

Methylglyoxal increases cardiomyocyte ischemia-reperfusion injury via glycative inhibition of thioredoxin activity.

Wang XL, Lau WB, Yuan YX, Wang YJ, Yi W, Christopher TA, Lopez BL, Liu HR, Ma XL.

Am J Physiol Endocrinol Metab. 2010 Aug;299(2):E207-14. doi: 10.1152/ajpendo.00215.2010. Epub 2010 May 11.

33.

Thioredoxin glycation: A novel posttranslational modification that inhibits its antioxidant and organ protective actions.

Yuan Y, Jiao X, Lau WB, Wang Y, Christopher TA, Lopez BL, Ramachandrarao SP, Tao L, Ma XL.

Free Radic Biol Med. 2010 Aug 1;49(3):332-8. doi: 10.1016/j.freeradbiomed.2010.04.017. Epub 2010 Apr 21.

34.

Reduced vascular responsiveness to adiponectin in hyperlipidemic rats--mechanisms and significance.

Li R, Xu M, Wang X, Wang Y, Lau WB, Yuan Y, Yi W, Wei X, Lopez BL, Christopher TA, Wang XM, Ma XL.

J Mol Cell Cardiol. 2010 Sep;49(3):508-15. doi: 10.1016/j.yjmcc.2010.03.002. Epub 2010 Mar 18.

35.

The dragon strikes: lessons from the Wenchuan earthquake.

Chen G, Lai W, Liu F, Mao Q, Tu F, Wen J, Xiao H, Zhang JC, Zhu T, Chen B, Hu ZY, Li RM, Liang Z, Nie H, Yan H, Yang BX, Du Q, Huang WX, Jiang YW, Kwan AS, Song L, Wu CM, Xiang T, Xu HW, Lau WB, Song HB, Wen CB, Yao ZH, Zhang L, Zeng J, Dai YE, Lopez BL, Zheng JQ, Zhou J, Christopher TA, Ma XL, Yu H, Xu LL, Guo Q, Song ZP, Volinn E, Kryger K, Cao Y, Ge H, Liu H, Luo CZ, Tao W, Zuo YX, Liu J.

Anesth Analg. 2010 Mar 1;110(3):908-15. doi: 10.1213/ANE.0b013e3181cbc62c. No abstract available.

PMID:
20185667
36.

Triage during the week of the Sichuan earthquake: a review of utilized patient triage, care, and disposition procedures.

Nie H, Tang SY, Lau WB, Zhang JC, Jiang YW, Lopez BL, Ma XL, Cao Y, Christopher TA.

Injury. 2011 May;42(5):515-20. doi: 10.1016/j.injury.2010.01.113. Epub 2010 Feb 13.

PMID:
20153857
37.

Prospective study of risk factors for conjunctival bacterial contamination in patients undergoing intraocular surgery.

Miño De Kaspar H, Ta CN, Froehlich SJ, Schaller UC, Engelbert M, Klauss V, Kampik A.

Eur J Ophthalmol. 2009 Sep-Oct;19(5):717-22.

PMID:
19787587
38.

One-day application of topical moxifloxacin 0.5% to select for fluoroquinolone-resistant coagulase-negative Staphylococcus.

He L, Ta CN, Miño de Kaspar H.

J Cataract Refract Surg. 2009 Oct;35(10):1715-8. doi: 10.1016/j.jcrs.2009.04.042.

PMID:
19781465
39.

A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections.

Moss JM, Sanislo SR, Ta CN.

Ophthalmology. 2009 Aug;116(8):1498-501. doi: 10.1016/j.ophtha.2009.02.024. Epub 2009 Jun 5.

PMID:
19501409
40.

Prospective randomized comparison of 1-day and 3-day application of topical 0.5% moxifloxacin in eliminating preoperative conjunctival bacteria.

He L, Ta CN, Hu N, Sinnar S, Miño de Kaspar H.

J Ocul Pharmacol Ther. 2009 Aug;25(4):373-8. doi: 10.1089/jop.2008.0102.

PMID:
19492956
41.

Cardioprotective effect of adiponectin is partially mediated by its AMPK-independent antinitrative action.

Wang Y, Tao L, Yuan Y, Lau WB, Li R, Lopez BL, Christopher TA, Tian R, Ma XL.

Am J Physiol Endocrinol Metab. 2009 Aug;297(2):E384-91. doi: 10.1152/ajpendo.90975.2008. Epub 2009 May 26.

42.

A prospective study determining the efficacy of topical 0.5% levofloxacin on bacterial flora of patients with chronic blepharoconjunctivitis.

Yactayo-Miranda Y, Ta CN, He L, Kreutzer TC, Nentwich MM, Kampik A, Mino de Kaspar H.

Graefes Arch Clin Exp Ophthalmol. 2009 Jul;247(7):993-8. doi: 10.1007/s00417-009-1039-0. Epub 2009 Feb 11.

PMID:
19205719
43.

AMP-activated protein kinase deficiency enhances myocardial ischemia/reperfusion injury but has minimal effect on the antioxidant/antinitrative protection of adiponectin.

Wang Y, Gao E, Tao L, Lau WB, Yuan Y, Goldstein BJ, Lopez BL, Christopher TA, Tian R, Koch W, Ma XL.

Circulation. 2009 Feb 17;119(6):835-44. doi: 10.1161/CIRCULATIONAHA.108.815043. Epub 2009 Feb 2.

44.

Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists.

Liu HR, Tao L, Gao E, Qu Y, Lau WB, Lopez BL, Christopher TA, Koch W, Yue TL, Ma XL.

Cardiovasc Res. 2009 Feb 1;81(2):344-52. doi: 10.1093/cvr/cvn308. Epub 2008 Nov 14.

45.

Comparison of one-day versus one-hour application of topical gatifloxacin in eliminating conjunctival bacterial flora.

Moss JM, Nguyen D, Liu YI, Singh K, Montague A, Egbert PR, Kaspar HM, Ta CN.

Ophthalmology. 2008 Nov;115(11):2013-6. doi: 10.1016/j.ophtha.2008.06.024. Epub 2008 Aug 16.

PMID:
18708260
46.

Prospective comparison of topical moxifloxacin in eliminating conjunctival bacterial flora following a one-day or one-hour application.

Ta CN, Chan I, Dhatt HS, Paterno J, Fisher E, Singh K, Montague A, Egbert PR, Cockerham G, Kaspar HM.

J Ocul Pharmacol Ther. 2008 Aug;24(4):427-31. doi: 10.1089/jop.2008.0018.

PMID:
18665815
47.

Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections.

de Caro JJ, Ta CN, Ho HK, Cabael L, Hu N, Sanislo SR, Blumenkranz MS, Moshfeghi DM, Jack R, de Kaspar HM.

Retina. 2008 Jun;28(6):877-83. doi: 10.1097/IAE.0b013e31816b3180.

PMID:
18536606
48.

Bioactive interpenetrating polymer network hydrogels that support corneal epithelial wound healing.

Myung D, Farooqui N, Zheng LL, Koh W, Gupta S, Bakri A, Noolandi J, Cochran JR, Frank CW, Ta CN.

J Biomed Mater Res A. 2009 Jul;90(1):70-81. doi: 10.1002/jbm.a.32056.

49.

Progress in the development of interpenetrating polymer network hydrogels.

Myung D, Waters D, Wiseman M, Duhamel PE, Noolandi J, Ta CN, Frank CW.

Polym Adv Technol. 2008 Apr 28;19(6):647-657.

50.

Development of hydrogel-based keratoprostheses: a materials perspective.

Myung D, Duhamel PE, Cochran JR, Noolandi J, Ta CN, Frank CW.

Biotechnol Prog. 2008 May-Jun;24(3):735-41. doi: 10.1021/bp070476n. Epub 2008 Apr 19. Review.

Supplemental Content

Loading ...
Support Center